Role of calcitriol in the management of osteoporosis

Hartmut H. Malluche; Marie Claude Faugere

doi:10.1016/0026-0495(90)90267-G

Role of calcitriol in the management of osteoporosis

Hartmut H. Malluche, Marie Claude Faugere

Internal Medicine

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Ovariohysterectomized Beagle dogs provide a useful model for the study of bone loss following cessation of ovarian function. Data obtained in our laboratory suggest that the sequence of events occurring after cessation of such function proceeds in two phases. The first, or "initiation," phase begins within 1 month after ovariohysterectomy (OHX). Although the number of osteoclasts is unchanged, there is an increase in trabecular separation, accompanied by a dramatic decrease in cancellous bone volume, which suggests an apparent dramatic hyperresorption. This early phase is followed by a "maintenance" phase, which commences in the second month and is related to an osteoblastic insufficiency. In another experiment, administration of 1,25(OH)₂D₃ corrected bone loss occurring after OHX in Beagle dogs. However, a positive balance between increased bone cell activity and decreased bone cell number was not maintained. This calls for new strategies to separate the positive effect of 1,25(OH)₂D₃ on bone cell activity from the negative effect on bone cell number.

Original language	English
Pages (from-to)	24-26
Number of pages	3
Journal	Metabolism: Clinical and Experimental
Volume	39
Issue number	4 SUPPL. 1
DOIs	https://doi.org/10.1016/0026-0495(90)90267-G
State	Published - Apr 1990

Bibliographical note

Funding Information:
From the Division of Nephrology. Bone and Mineral Metabolism, Department of Medicine, University of Kentucky Medical Center, Lexington. KY. Supported in part by National Institutes of Health Grant No. ROIAR35837. Address reprint requests to Hartmut H. Malluche. MD, University of Kentucky Medical Center, Division of Nephrology, Bone and Mineral Metabolism, Room 572, 800 Rose St, Lexington, KY 405360084. o 1990 by W.B. Saunders Company. 0026-0495/90/3904-1009$3.00/O

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/0026-0495(90)90267-G

Cite this

@article{27d9f855bee5497a8ecaad0a14fd3937,

title = "Role of calcitriol in the management of osteoporosis",

abstract = "Ovariohysterectomized Beagle dogs provide a useful model for the study of bone loss following cessation of ovarian function. Data obtained in our laboratory suggest that the sequence of events occurring after cessation of such function proceeds in two phases. The first, or {"}initiation,{"} phase begins within 1 month after ovariohysterectomy (OHX). Although the number of osteoclasts is unchanged, there is an increase in trabecular separation, accompanied by a dramatic decrease in cancellous bone volume, which suggests an apparent dramatic hyperresorption. This early phase is followed by a {"}maintenance{"} phase, which commences in the second month and is related to an osteoblastic insufficiency. In another experiment, administration of 1,25(OH)2D3 corrected bone loss occurring after OHX in Beagle dogs. However, a positive balance between increased bone cell activity and decreased bone cell number was not maintained. This calls for new strategies to separate the positive effect of 1,25(OH)2D3 on bone cell activity from the negative effect on bone cell number.",

author = "Malluche, {Hartmut H.} and Faugere, {Marie Claude}",

note = "Funding Information: From the Division of Nephrology. Bone and Mineral Metabolism, Department of Medicine, University of Kentucky Medical Center, Lexington. KY. Supported in part by National Institutes of Health Grant No. ROIAR35837. Address reprint requests to Hartmut H. Malluche. MD, University of Kentucky Medical Center, Division of Nephrology, Bone and Mineral Metabolism, Room 572, 800 Rose St, Lexington, KY 405360084. o 1990 by W.B. Saunders Company. 0026-0495/90/3904-1009$3.00/O",

year = "1990",

month = apr,

doi = "10.1016/0026-0495(90)90267-G",

language = "English",

volume = "39",

pages = "24--26",

number = "4 SUPPL. 1",

}

TY - JOUR

T1 - Role of calcitriol in the management of osteoporosis

AU - Malluche, Hartmut H.

AU - Faugere, Marie Claude

N1 - Funding Information: From the Division of Nephrology. Bone and Mineral Metabolism, Department of Medicine, University of Kentucky Medical Center, Lexington. KY. Supported in part by National Institutes of Health Grant No. ROIAR35837. Address reprint requests to Hartmut H. Malluche. MD, University of Kentucky Medical Center, Division of Nephrology, Bone and Mineral Metabolism, Room 572, 800 Rose St, Lexington, KY 405360084. o 1990 by W.B. Saunders Company. 0026-0495/90/3904-1009$3.00/O

PY - 1990/4

Y1 - 1990/4

N2 - Ovariohysterectomized Beagle dogs provide a useful model for the study of bone loss following cessation of ovarian function. Data obtained in our laboratory suggest that the sequence of events occurring after cessation of such function proceeds in two phases. The first, or "initiation," phase begins within 1 month after ovariohysterectomy (OHX). Although the number of osteoclasts is unchanged, there is an increase in trabecular separation, accompanied by a dramatic decrease in cancellous bone volume, which suggests an apparent dramatic hyperresorption. This early phase is followed by a "maintenance" phase, which commences in the second month and is related to an osteoblastic insufficiency. In another experiment, administration of 1,25(OH)2D3 corrected bone loss occurring after OHX in Beagle dogs. However, a positive balance between increased bone cell activity and decreased bone cell number was not maintained. This calls for new strategies to separate the positive effect of 1,25(OH)2D3 on bone cell activity from the negative effect on bone cell number.

AB - Ovariohysterectomized Beagle dogs provide a useful model for the study of bone loss following cessation of ovarian function. Data obtained in our laboratory suggest that the sequence of events occurring after cessation of such function proceeds in two phases. The first, or "initiation," phase begins within 1 month after ovariohysterectomy (OHX). Although the number of osteoclasts is unchanged, there is an increase in trabecular separation, accompanied by a dramatic decrease in cancellous bone volume, which suggests an apparent dramatic hyperresorption. This early phase is followed by a "maintenance" phase, which commences in the second month and is related to an osteoblastic insufficiency. In another experiment, administration of 1,25(OH)2D3 corrected bone loss occurring after OHX in Beagle dogs. However, a positive balance between increased bone cell activity and decreased bone cell number was not maintained. This calls for new strategies to separate the positive effect of 1,25(OH)2D3 on bone cell activity from the negative effect on bone cell number.

UR - http://www.scopus.com/inward/record.url?scp=0025354930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025354930&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(90)90267-G

DO - 10.1016/0026-0495(90)90267-G

M3 - Article

C2 - 2325567

AN - SCOPUS:0025354930

SN - 0026-0495

VL - 39

SP - 24

EP - 26

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

IS - 4 SUPPL. 1

ER -

Role of calcitriol in the management of osteoporosis

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this